SAN DIEGO, Aug. 28, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 10, 2012 at 2:25 p.m. Eastern time, in the Starlight Center Salon at The Waldorf Astoria hotel in New York City.
Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals web site at http://www.adventrx.com/. An archived presentation will be available on the web site for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company developing proprietary product candidates to treat various diseases and conditions. The Company's lead product candidate, ANX-188, has potential to reduce ischemic tissue injury and end-organ damage by restoring microvascular function which is compromised in a wide range of serious and life-threatening diseases and conditions. The Company initially is developing ANX-188 as a treatment for complications arising from sickle cell disease. More information can be found on the Company's web site at http://www.adventrx.com/.
SOURCE ADVENTRX Pharmaceuticals, Inc.
Ioana C. Hone, +1-858-552-0866 Ext. 303, ir@adventrx.com
